Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 8.07%-432.12K | -156.44%-697K | -119.62%-532.72K | 147.33%555.71K | 33.61%-249.94K | -769.15%-470.06K | 224.64%1.23M | 203.34%2.72M | -576.08%-1.17M | 37.28%-376.47K |
| Net income from continuing operations | 56.50%-476.57K | -199.52%-2.59M | -122.10%-722.72K | 111.75%137.16K | -115.77%-908.96K | -218.86%-1.1M | 211.10%2.6M | 255.21%3.27M | -323.20%-1.17M | -126.41%-421.26K |
| Operating gains losses | -82.45%27.69K | 139.45%293.51K | -110.64%-51.76K | 130.58%100.21K | 130.77%87.34K | 125.48%157.73K | -21.99%-743.99K | -21.50%486.49K | 47.04%-327.7K | 60.70%-283.81K |
| Depreciation and amortization | -8.67%179.25K | 31.31%709.2K | -35.03%160.31K | 69.81%168.41K | 91.40%184.21K | 100.47%196.27K | 189.70%540.09K | 43.99%246.77K | 1,255.76%99.17K | 1,216.91%96.24K |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | -97.07%18.22K | ---- | ---- | ---- |
| Remuneration paid in stock | -70.68%23.33K | -8.27%245.75K | --0 | -73.72%86.91K | --79.27K | --79.57K | 11.78%267.91K | -4,032.83%-62.77K | 34,781.12%330.67K | --0 |
| Deferred tax | -470.30%-128K | 176.62%581K | 159.42%450.59K | --46.05K | --49.8K | --34.57K | ---758.31K | ---758.31K | --0 | --0 |
| Other non cashItems | --9.53K | 1,620,900.00%16.21K | 463,400.00%9.27K | ---- | ---- | ---- | --1 | --2 | ---- | ---- |
| Change In working capital | -142.78%-67.34K | 106.86%47.44K | 38.04%-378.41K | -42.22%10.03K | 11.21%258.41K | 147.63%157.41K | -175.65%-691.52K | -138.47%-610.76K | 120.13%17.36K | 265.73%232.35K |
| -Change in receivables | -200.63%-307.92K | 179.47%187.64K | -311.64%-467.47K | 158.95%210.07K | 291.51%139.04K | 1,190.85%305.99K | -130.85%-236.11K | -88.59%220.88K | 71.58%-356.34K | 38.47%-72.6K |
| -Change in prepaid assets | ---- | --0 | ---- | ---- | ---- | ---- | --225K | ---- | ---- | ---- |
| -Change in payables and accrued expense | 285.24%275.23K | -135.96%-186.85K | 143.88%42.41K | -153.53%-200.04K | -60.86%119.37K | -138.04%-148.58K | 140.08%519.59K | -288.89%-96.64K | 1,258.51%373.7K | 68.00%304.95K |
| -Change in other working capital | ---34.65K | 103.89%46.65K | ---- | ---- | ---- | ---- | -250.00%-1.2M | -140.00%-960K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 8.07%-432.12K | -156.44%-697K | -119.62%-532.72K | 147.33%555.71K | 33.61%-249.94K | -769.15%-470.06K | 224.64%1.23M | 203.34%2.72M | -576.08%-1.17M | 37.28%-376.47K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 9.40%-212.82K | 70.31%-902.76K | -123.03%-188.5K | 116.21%585.39K | -436.52%-1.06M | -369.45%-234.9K | -36.31%-3.04M | 161.58%818.66K | -186.21%-3.61M | -127.78%-198.46K |
| Net PPE purchase and sale | 9.40%-212.82K | -254.79%-1.36M | -2,740.47%-1.03M | 7.42%-298.5K | 524.03%205.47K | -369.45%-234.9K | 75.09%-381.99K | 102.54%38.91K | -17,095.57%-322.41K | -25,538.10%-48.46K |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---205.23K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net business purchase and sale | ---- | --0 | --0 | ---- | ---- | ---- | -114.30%-2.86M | 288.95%779.11K | ---- | ---- |
| Net other investing changes | ---- | 130.28%452.5K | --0 | 214.90%1.09M | ---- | ---- | -69.07%196.5K | --638 | 127.37%345.86K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 9.40%-212.82K | 70.31%-902.76K | -123.03%-188.5K | 116.21%585.39K | -436.52%-1.06M | -369.45%-234.9K | -36.31%-3.04M | 161.58%818.66K | -186.21%-3.61M | -127.78%-198.46K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -495.06%-292.33K | -114.33%-618.33K | 108.93%410.49K | -104.12%-313.42K | -160.77%-789.39K | 74K | 206.73%4.31M | -16,708.34%-4.6M | 452.03%7.61M | 1.3M |
| Net issuance payments of debt | -476.80%-278.81K | -117.87%-449.58K | 95.43%-240.9K | -95.49%351.39K | ---634.06K | --74K | 78.85%2.52M | -19,139.25%-5.27M | --7.78M | --0 |
| Net common stock issuance | ---- | -48.25%877.21K | 12,658.43%877.21K | --0 | ---- | ---- | --1.7M | ---6.99K | --403.2K | ---- |
| Net other financing activities | ---13.51K | -1,114.08%-1.05M | -133.23%-225.82K | ---664.8K | ---- | ---- | --103.14K | --679.64K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -495.06%-292.33K | -114.33%-618.33K | 108.93%410.49K | -104.12%-313.42K | -160.77%-789.39K | --74K | 206.73%4.31M | -16,708.34%-4.6M | 452.03%7.61M | --1.3M |
| Net cash flow | ||||||||||
| Beginning cash position | -60.18%1.27M | 419.97%3.18M | 22.34%1.58M | -61.13%527.15K | 264.32%2.16M | 419.97%3.18M | -75.98%611.92K | -8.15%1.3M | 18.91%1.36M | -36.79%592.19K |
| Current changes in cash | -48.67%-937.26K | -188.46%-2.22M | 70.74%-310.73K | -70.68%827.69K | -389.66%-2.1M | -3,219.35%-630.42K | 238.11%2.51M | -161.07%-1.06M | 5,071.46%2.82M | 536.14%726.58K |
| Effect of exchange rate changes | 107.97%31.39K | 385.46%303.35K | -100.24%-7.07K | 107.98%230.05K | 1,168.32%474.3K | -886.23%-393.93K | 152.10%62.49K | 852.61%2.95M | -982.60%-2.88M | -58.18%37.4K |
| End cash Position | -83.26%361.21K | -60.18%1.27M | -60.18%1.27M | 22.34%1.58M | -61.13%527.15K | 264.32%2.16M | 419.97%3.18M | 419.97%3.18M | -8.15%1.3M | 18.91%1.36M |
| Free cash from | 8.51%-644.93K | -340.62%-2.05M | -126.19%-721.22K | 103.47%51.98K | -59.57%-678.07K | -3,588.15%-704.96K | 133.79%852.92K | 533.91%2.75M | -771.26%-1.5M | 29.23%-424.93K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.